The Food and Drug Administration warning letter detailed unreported low blood sugar and a software change to correct for delayed glucose readings.
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (BBNX), a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its ...
Abbott Laboratories is back with another collaboration in the diabetes tech space. The Abbott Park, IL-based company announced an agreement with Beta Bionics, the developer of the iLet Bionic Pancreas ...
SAN ANTONIO, Texas (Ivanhoe Newswire) – The FDA recently approved a device for diabetics, called the “bionic pancreas,” taking much of the burden of continually entering carb intake, off the user.
Beta Bionics Inc., which makes ­a “bionic pancreas,” has secured $60 million in a Series E funding round led by new investor Wellington Management. The funding fuels Beta Bionics’ continued ...
Abbott Laboratories (NYSE:ABT) is one of the high profit margin stocks to buy now. On June 19, Beta Bionics Inc. (NASDAQ:BBNX) announced its plan to integrate its iLet Bionic Pancreas automated ...
BATON ROUGE, La. (WAFB) - The FDA recently approved a device for diabetics, called the “bionic pancreas,” taking much of the burden of continually entering carb intake, off the user. With one entry ...